Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 893441-86-6 | MDL No. : | MFCD14155783 |
Formula : | C19H26BNO4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | FUXWYWGKVFEKQX-UHFFFAOYSA-N |
M.W : | 343.23 | Pubchem ID : | 60204498 |
Synonyms : |
|
Num. heavy atoms : | 25 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.53 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 100.62 |
TPSA : | 49.69 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | Yes |
Log Kp (skin permeation) : | -5.37 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 4.26 |
Log Po/w (WLOGP) : | 3.72 |
Log Po/w (MLOGP) : | 2.43 |
Log Po/w (SILICOS-IT) : | 2.16 |
Consensus Log Po/w : | 2.52 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -4.65 |
Solubility : | 0.00761 mg/ml ; 0.0000222 mol/l |
Class : | Moderately soluble |
Log S (Ali) : | -5.02 |
Solubility : | 0.00331 mg/ml ; 0.00000965 mol/l |
Class : | Moderately soluble |
Log S (SILICOS-IT) : | -4.92 |
Solubility : | 0.00411 mg/ml ; 0.000012 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 3.42 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
75.8% | With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In dimethyl sulfoxide at 80℃; for 12 h; Inert atmosphere | [0688] To a solution of fert-butyl 4-bromo-lH-indole-l -carboxylate (LXX) (9 g, 30 mmol) and bis(pinacolato)diboron (8.45 g, 33 mmol) in DMSO (180 mL) was added KOAc (9 g, 91 mmol). The suspension was purged with nitrogen (3x) before adding Pd(dppf)Cl2 (744 mg, 912 μιηο). The reaction was stirred at 80°C for 12 h. The suspension was poured into water (400 mL) and extracted with EtOAc (300 mL x 2). The combined organic layer was washed with brine (200 mL), dried over Na2S04 and concentrated under reduced pressure. Then the crude product was purified by silica gel (PE:EtOAc = 40: 1) to give fert-butyl 4-(4,4,5,5-tetramethyl-l,3,2- dioxaborolan-2-yl)-lH-indole-l-carboxylate (LXXXI) (7.8 g, 22.7 mmol, 75.8percent yield) as a white solid. NMR (CDCI3, 400 MHz) δ ppm 1.38 (s, 12H), 1.68 (s, 9H), 7.09 (d, J=3.6Hz, IH), 7.30 (t, J=7.6Hz, IH), 7.61 (d, J=3.2Hz, IH), 7..70 (d, J=7.2Hz, IH), 8.24 (d, J=8Hz, IH); ESIMS found for C19H26BNO4 mlz 344.1 (M+H). |
75.8% | With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In dimethyl sulfoxide at 80℃; for 12 h; Inert atmosphere | To a solution of fert-butyl 4-bromo- lH-indole- 1 -carboxylate (LXXXVIII) (9 g, 30 mmol) and bis(pinacolato)diboron (8.45 g, 33 mmol) in DMSO (180 mL) was added KOAc (9 g, 91 mmol). The suspension was purged with nitrogen (3x) before adding Pd(dppf)Cl2 (744 mg, 912 μιηο). The reaction was stirred at 80°C for 12 h. The suspension was poured into water (400 mL) and extracted with EtOAc (300 mL x 2). The combined organic layer was washed with brine (200 mL), dried over Na2S04 and concentrated under reduced pressure . Then the crude product was purified by silica gel (PE:EtOAc = 40: 1) to give fert-butyl 4-(4,4,5,5-tetramethyl-l,3,2- dioxaborolan-2-yl)-lH-indole-l-carboxylate (XCVIII) (7.8 g, 22.7 mmol, 75.8percent yield) as a white solid. NMR (CDCI3, 400 MHz) δ ppm 1.38 (s, 12H), 1.68 (s, 9H), 7.09 (d, J=3.6Hz, IH), 7.30 (t, J=7.6Hz, IH), 7.61 (d, J=3.2Hz, IH), 7..70 (d, J=7.2Hz, IH), 8.24 (d, J=8Hz, IH); ESIMS found for C19H26BNO4 mlz 344.1 (M+H). |
75.8% | With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In dimethyl sulfoxide at 80℃; for 12 h; Inert atmosphere | To a solution of tert-butyl 4-bromo-1H-indole-1-carboxylate (LXX) (9 g, 30 mmol) and bis(pinacolato)diboron (8.45 g, 33 mmol) in DMSO (180 mL) was added KOAc (9 g, 91 mmol). The suspension was purged with nitrogen (3x) before adding Pd(dppf)Cl2 (744 mg, 912 μmol). The reaction was stirred at 80°C for 12 h. The suspension was poured into water (400 mL) and extracted with EtOAc (300 mL x 2). The combined organic layer was washed with brine (200 mL), dried over Na2SO4 and concentrated under reduced pressure. Then the crude product was purified by silica gel (PE:EtOAc = 40: 1) to give fert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate (LXXXI) (7.8 g, 22.7 mmol, 75.8percent yield) as a white solid. 1H NMR (CDCl3, 400 MHz) δ ppm 1.38 (s, 12H), 1.68 (s, 9H), 7.09 (d, J=3.6Hz, IH), 7.30 (t, J=7.6Hz, IH), 7.61 (d, J=3.2Hz, IH), 7..70 (d, J=7.2Hz, IH), 8.24 (d, J=8Hz, IH); ESIMS found for C19H26BNO4 m/z 344.1 (M+H). |
75.8% | With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In dimethyl sulfoxide at 80℃; for 12 h; Inert atmosphere | To a solution of tert-butyl 4-bromo-1H-indole-1-carboxylate (LXX) (9 g, 30 mmol) and bis(pinacolato)diboron (8.45 g, 33 mmol) in DMSO (180 mL) was added KOAc (9 g, 91 mmol). The suspension was purged with nitrogen (3x) before adding Pd(dppf)C12 (744 mg, 912 .imol). The reaction was stirred at 80°C for 12 h. The suspension was poured into water (400 mL) and extracted with EtOAc (300 mL x 2). The combined organic layer was washed with brine (200 mL), dried over Na2504 and concentrated under reduced pressure. Then the cmde product was purified by silica gel (PE:EtOAc = 40:1) to give tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2- dioxaborolan-2-yl)-1H-indole-1-carboxylate (LXXXI) (7.8 g, 22.7 mmol, 75.8percent yield) as a white solid. ‘HNMR(CDC13, 400 MHz) ppm 1.38 (s, 12H), 1.68 (s, 9H), 7.09 (d, J=3.6Hz, 1H), 7.30 (t,J=7.6Hz, 1H), 7.61 (d,J=3.2Hz, 1H), 7.70 (d,J=7.2Hz, 1H), 8.24 (d,J=8Hz, 1H); ESIMS found for C19H26BN04 mlz 344.1 (M+H). |
[ 942070-45-3 ]
tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate
Similarity: 0.96
[ 1235451-62-3 ]
tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indoline-1-carboxylate
Similarity: 0.91
[ 1218790-30-7 ]
tert-Butyl 5-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate
Similarity: 0.86
[ 2102451-30-7 ]
(1-(tert-Butoxycarbonyl)-1H-indol-4-yl)boronic acid
Similarity: 0.85
[ 470478-90-1 ]
tert-Butyl 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine-1-carboxylate
Similarity: 0.84
[ 942070-45-3 ]
tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate
Similarity: 0.96
[ 1235451-62-3 ]
tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indoline-1-carboxylate
Similarity: 0.91
[ 1218790-30-7 ]
tert-Butyl 5-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate
Similarity: 0.86
[ 2102451-30-7 ]
(1-(tert-Butoxycarbonyl)-1H-indol-4-yl)boronic acid
Similarity: 0.85
[ 470478-90-1 ]
tert-Butyl 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine-1-carboxylate
Similarity: 0.84
[ 942070-45-3 ]
tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate
Similarity: 0.96
[ 1218790-30-7 ]
tert-Butyl 5-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate
Similarity: 0.86
[ 2102451-30-7 ]
(1-(tert-Butoxycarbonyl)-1H-indol-4-yl)boronic acid
Similarity: 0.85
[ 181365-26-4 ]
(1-(tert-Butoxycarbonyl)-1H-indol-3-yl)boronic acid
Similarity: 0.82
[ 388116-27-6 ]
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole
Similarity: 0.78